Organizations Upping Pace of Healthcare Big Data, AI Investments

More than three-quarters of healthcare C-suite executives are increasing their pace of investment in healthcare big data and artificial intelligence (AI), according to a recent survey by NewVantage Partners. Around 79 percent of senior healthcare executives said they have a greater urgency for investing in big data and AI initiatives. For the survey, NewVantage Partners polled C-suite executives at 65 industry leading firms in a variety of industries, including healthcare, financial services, insurance, and media. The 2019 survey saw a doubling of participation from healthcare senior executives. Healthcare and life sciences respondents included senior executives from Aetna, Alexion, Astellas, Astra Zeneca, Cigna, CVS Health, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Parexel, Partners Healthcare, Sanofi, and United Health. Healthcare big data and AI investments are motivated positively by the need for business transformation and increased agility and negatively by fear of competition and disruptive forces.